Zobrazeno 1 - 10
of 649
pro vyhledávání: '"J. C. Job"'
Autor:
Muriel Letrait, P Rochiccioli, Pierre Chatelain, Jean Claude Carel, Jean Pierre Tresca, Chaussain Jl, J C Job, Joёl Coste
Publikováno v:
BMJ. 315:708-713
OBJECTIVES: To describe the growth of children treated with growth hormone and to evaluate the prognostic factors for height at the end of treatment. DESIGN: Register based cohort study. SETTING: French national register of all children treated with
Publikováno v:
Hormone Research. 38:35-43
Because the delivery of growth hormone (GH) was centralized from 1977 in France, it has been possible to conduct, during the second half of 1990, a nationwide survey of the health status of patients treated with GH from the year 1959. A questionnaire
Autor:
G. Magnin, L. Larget-Piet, Charles Belon, R Moustarih, M. Vanderschueren, S. Bernasconi, J C Job, Jean-Edmond Toublanc, P. Lecomte, A Terraza, H. Chaabouni, D. Schoenberg, J M Lobaccaro, N. Bouccekine, M. Bost, Mongia Hachicha, Margherita Bozzola, P Rochiccioli, Ch. Sultan, Jean-Louis Chaussain, J M Limal, Michael B. Ranke, C. Burési, C. Moraine, J L Nivelon, G Malpuech, J Battin
Publikováno v:
Hormone Research. 37:54-59
In patients with androgen insensitivity syndrome (AIS), RFLP study of the androgen receptor gene made it possible to analyze whether deletions or mutations could be responsible for abnormalities in androgen responsiveness. We studied RFLPs of DNA fro
Publikováno v:
Hormone and Metabolic Research. 23:281-284
This study of the human growth hormone binding protein (GHBP) was undertaken using several samples of hGH, extractive or recombinant, from different origins. They were labelled in identical conditions and assayed by gel chromatography after incubatio
Autor:
Raphaël Rappaport, F. Dray, P. Rochiccioli, F. Girard, C. Rougeot, P.M. Marchand, J C Job, M. Pierson, Claude Ponte
Publikováno v:
Hormone Research. 35:76-81
The immunogenicities of six recombinant human growth hormone (rhGH) preparations, from KABI (A rhGH191 and B rhGH192), Eli Lilly (C), Nordisk (D), Sanofi (E) and Serono (F), used to treat 260 GH-deficient children, have been compared using a common s
Autor:
Claude Ponte, M. Tauber, Felice Uboldi, Reinhard Ziegler, J C Job, C. Rougeot, P. Rochiccioli, Friedhelm Raue, P.M. Marchand, M. Pierson, T.H. Jones, Catherine Pienkowski, A. Zink, F. Girard, Richard Hoffmann, F. Dray, Raphaël Rappaport, P Rochiccioli, Christian Enjaume
Publikováno v:
Hormone Research. 35:45-69
Publikováno v:
Hormone Research. 34:17-22
The serum levels of insulin-like growth factor I (IGF I), dehydroepiandrosterone sulfate (DHAS), testosterone (T) and estradiol (E2) have been measured in 78 prepubertal and 57 early pubertal patients referred for short stature, at the same time when
Autor:
L T, Rekers-Mombarg, G G, Massa, J M, Wit, A M, Matranga, J M, Buckler, O, Butenandt, J L, Chaussain, H, Frisch, E, Leiberman, R, Yturriaga, D, Aarskog, P G, Chatelain, M, Colle, C, Dacou-Voutetakis, H A, Delemarre-van de Waal, F, Girard, J J, Gosen, U, Irle, M, Jansen, R, Jean, J C, Job, M L, Kaar, F, Kollemann, H L, Lenko, J J, Waelkens
Publikováno v:
The Journal of pediatrics. 132(3 Pt 1)
In children with idiopathic short stature (ISS) we studied the growth-promoting effect at 4 years of recombinant human growth hormone (rhGH) therapy in three dose regimens and evaluated whether increasing the dosage after the first year could prevent
Autor:
M Olivier, B Job, J C Job, Pierre Chatelain, J P Ducret, C. Ponte, Magda Vanderschueren-Lodeweyckx, Jean-Louis Chaussain, M Maes, P Rochiccioli
Publikováno v:
Pediatric research. 39(2)
Seventy-eight prepubertal, non-GH-deficient children aged 8.1 +/- 0.2 y, with very short stature (mean, -3.2 SD) of intrauterine onset, were treated for 3 y with GH [0.4 (dose D1) or 1.2 (dose D2) IU/kg/wk] and 66 were followed during a 4th y without
Autor:
P. Rochiccioli, M. Pierson, J C Job, S Cabrol, R. Mariani, M. Colle, M. Lecornu, Bruno Leheup, Michel David, M. Tauber, Pierre Chatelain, Anne-Marie Bertrand, M. Bost, Claude Ponte, Y. Le Bouc, Jean-Louis Chaussain, Paul Czernichow, Jacques Battin, Raphaël Rappaport, Jean-Marie Limal
Publikováno v:
Hormone research. 44(4)
The first treatment trials on patients presenting with Turner syndrome were successful in accelerating growth velocity. It is therefore essential to know the final height of the patients who were treated in order to ascertain whether or not growth ho